FHUMX
Price
$15.62
Change
-$0.12 (-0.76%)
Updated
Aug 6 closing price
Net Assets
4.7M
FSMAX
Price
$94.95
Change
+$0.02 (+0.02%)
Updated
Aug 6 closing price
Net Assets
39.63B
Interact to see
Advertisement

FHUMX vs FSMAX

Header iconFHUMX vs FSMAX Comparison
Open Charts FHUMX vs FSMAXBanner chart's image
Federated Hermes US SMID Institutional
Price$15.62
Change-$0.12 (-0.76%)
VolumeN/A
Net Assets4.7M
Fidelity Extended Market Index
Price$94.95
Change+$0.02 (+0.02%)
VolumeN/A
Net Assets39.63B
FHUMX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FHUMX vs. FSMAX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHUMX is a Buy and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. FHUMX (4.7M). FSMAX pays higher dividends than FHUMX: FSMAX (0.46) vs FHUMX (0.10). FHUMX was incepted earlier than FSMAX: FHUMX (5 years) vs FSMAX (14 years). FHUMX (6.45) is less costly to investors than FSMAX (0.04). FHUMX is a more actively managed with annual turnover of: 24.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than FHUMX: FSMAX (0) vs FHUMX (1000000). FSMAX annual gain was more profitable for investors over the last year : 20.34 vs. FHUMX (4.20). FSMAX return over 5 years is better than : 51.31 vs. FHUMX (48.73).
FHUMXFSMAXFHUMX / FSMAX
Total Expense Ratio0.830.042,371%
Annual Report Gross Expense Ratio6.450.0418,429%
Fund Existence5 years14 years-
Gain YTD1.6144.45636%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.7M39.6B0%
Annual Yield % from dividends0.100.4621%
Returns for 1 year4.2020.3421%
Returns for 3 years21.8738.6957%
Returns for 5 years48.7351.3195%
Returns for 10 yearsN/A84.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKRO52.793.23
+6.52%
Akero Therapeutics
PCG15.13-0.04
-0.26%
PG&E Corp
QTTB1.95-0.03
-1.52%
Q32 Bio
LASR19.67-1.26
-6.02%
nLIGHT
BTMD3.86-0.31
-7.43%
Biote Corp